We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 5,887

Seventh Circuit Grants Interlocutory Appeal in Rx Discount Program Qui Tam Suit to Answer Several Important Questions
  • Ropes & Gray LLP
  • USA
  • March 29 2017

In United States ex rel. Garbe v. Kmart Co., 824 F.3d 632 (7th Cir. 2016), the Seventh Circuit granted interlocutory appeal following numerous motions


Break Out the Pom-Poms
  • Bradley Arant Boult Cummings LLP
  • USA
  • March 28 2017

We’re all familiar with the sight. Your team is down in the final minutes of the game but within striking distance. The coach calls a timeout


Second Circuit Addresses Title VII Sexual Orientation Claims And Leaves Door Ajar For Sex Stereotyping Claims
  • Proskauer Rose LLP
  • USA
  • March 28 2017

In a three-member panel decision in Christiansen v. Omnicom Group, Inc., the Second Circuit revived a homosexual employee’s claims under Title VII on


IPRs Are Not Time Barred by an Earlier ITC Complaint
  • Jones Day
  • USA
  • March 28 2017

Since their introduction as part of the America Invents Act, Inter Partes Reviews (IPRs) have proven to be a powerful tool for parties accused on


ITC Proceedings Do Not Trigger One Year Clock to File IPR
  • Jones Day
  • USA
  • March 28 2017

Increasing use of Inter Partes Reviews (IPRs) by patent stakeholders and an increase in the number of ITC complaints heighten the importance of an


Healthcare Law Update: March 2017
  • Holland & Knight LLP
  • USA
  • March 24 2017

On March 3, 2017, the U.S. Department of Health and Human Services' (HHS) Office of Inspector General (OIG) issued Advisory Opinion 17-01 (Opinion


Unsuccessfully Using the Wayback Machine to Establish Status as a Printed Publication
  • Jones Day
  • USA
  • March 24 2017

On March 6, 2017, the PTAB issued a pair of final written decisions upholding the patentability of U.S. Patent Nos. 7,932,268 (IPR2015-01836) and 8


CBCA Affirms It Cannot Direct an Agency to Revise a CPAR
  • Morrison & Foerster LLP
  • USA
  • March 23 2017

The Civilian Board of Contract Appeals (CBCA) recently affirmed that it would follow the Court of Federal Claims (COFC) and Armed Services Board of


Shzoom Requests the Federal Circuit Reissue Trading Technologies as Precedential Opinion
  • Fenwick & West LLP
  • USA
  • March 22 2017

On January 18, 2017 the Federal Circuit issued an opinion in Trading Technologies Int’l., Inc. v. CQG, Inc., its first decision finding a user


Legal Alert: Laches Unavailable as a Defense to Patent Claims Brought within 286’s Damages Period
  • Fish & Richardson PC
  • USA
  • March 22 2017

In a 7-1 opinion, the Supreme Court has vacated the Federal Circuit’s en banc opinion holding that laches remains a defense in most patent